Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Argentina

GSK Trial Raises Regulatory Questions

July 2008 | Industry News

The Federation of Health Professionals of Argentina (Fesprosa) has called for an investigation by the country's pharmaceutical regulator ANMAT into an ongoing phase IIIb clinical trial of UK-based

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Eating Disorders To Be Recognised As Diseases

Industry / Argentina In a ruling that will have major implications for the country's healthcare system Argentina's senate has passed a law that recognises eating disorders, including obesity, anorexia and bulimia, as diseases....
August 2008
State-Owned Factories Win Government Contract

Industry / Argentina Argentina's Ministry of Health has granted a major contract to state medicine producers in a bid to support local pharmaceutical production. A contract worth ARS37mn (US$12.2mn) has been granted to 10...
August 2008
Clinical Trials Regulation Strengthened

Industry / Argentina Argentina is to introduce new rules governing clinical trials from March, lending weight to BMI's view that the country's regulatory environment is on an upward trajectory. The rules should bring clinical...
February 2008
Move Towards International Manufacturing Standards Leads To BER Upgrade

Companies / Argentina Following positive steps by Argentina to improve its regulatory environment, BMI has upgraded the country's Business Environment Rating (BER) for the Approvals Process subcategory from 4 to 6. Our dramatic...
December 2007
ANMAT Follows US FDA's Lead

Industry / Argentina Two recent decisions by Argentina's medicines regulator ANMAT that mirror directives issued by the US FDA have served to demonstrate that it is watching the US regulator closely when making decisions...
November 2007


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS